Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6466210

CCN(CC)CCOc1ccc2nc(Nc3nc(O)c4cc(N)cc(C)c4n3)nc(C)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.39
YES1 P07947 1/20 0.38
KDM4E B2RXH2 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 4/20 0.37
AURKA O14965 1/20 0.36
MAOB P27338 1/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
USP2 O75604 1/20 0.35
RAB9A P51151 1/20 0.35
STAT3 P40763 1/20 0.35
AVPR1B P47901 1/20 0.35
MCHR1 Q99705 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
PSMD14 O00487 1/20 0.34
APAF1 O14727 1/20 0.34
MITF O75030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6469682 0.89 KDM4E (0.39) KDM4EMEN1KMT2AGAAMAPT
SCHEMBL6466218 0.88 SRC (0.38) SRCYES1KDM4EMEN1KMT2A
Trifluoroacetic Acid SCHEMBL6470554 0.85 KDM4E (0.46) KDM4EMEN1KMT2AMAPTLMNA
Trifluoroacetic Acid SCHEMBL6465761 0.84 AURKA (0.39) SRCYES1KDM4EMEN1KMT2A
Trifluoroacetic Acid SCHEMBL6467968 0.83 KDR (0.41) KDM4EMEN1KMT2AMAPTAURKA
Trifluoroacetic Acid SCHEMBL6470895 0.83 MEN1 (0.37) KDM4EMEN1KMT2AGAAMAPT
Trifluoroacetic Acid SCHEMBL6467347 0.79 FGFR2 (0.38) KDM4EMEN1KMT2AMAPTAURKA
Trifluoroacetic Acid SCHEMBL6467477 0.79 TLR7 (0.36) KDM4EMEN1KMT2AGAAMAPT
Trifluoroacetic Acid SCHEMBL6469301 0.79 KDR (0.37) KDM4EMEN1KMT2AMAPTAURKA
Trifluoroacetic Acid SCHEMBL6467460 0.78 KDM4E (0.45) KDM4EMEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB SRC 4282/4885YES1 3611/4885KDM4E 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.